Three industrial stocks, Kennametal, Mueller Water Products and Trimble, are poised to beat Q4 earnings, driven by strong end-market demand and...

ALB, SQM and MEOH face weak end-market demand, but self-help measures, including cost cuts and productivity gains, position them to beat Q4 earnings...

ALB, SQM and MEOH face weak end-market demand, but self-help measures, including cost cuts and productivity gains, position them to beat Q4 earnings...

MCHP beats Q3 earnings estimates and raises its Q4 outlook, but shares dip despite double-digit sales.

Q4 2025 sets the stage for SPG, REG, KIM and FRT to potentially beat earnings amid steady retail demand.

Q4 2025 sets the stage for SPG, REG, KIM and FRT to potentially beat earnings amid steady retail demand.

Let us look at some drug/biotech stocks, ZTS, PCRX, APLS, ACAD and DNLI, which are poised to beat on fourth-quarter 2025 earnings.

AI-driven semiconductor sales hit record highs, putting funds JNGTX, PRSCX and FSELX in focus as chip demand and investment surge.

Amgen delivers Q4 earnings and revenue beat, driven by strong drug volumes, as attention turns to its late-stage MariTide obesity studies.

Amgen delivers Q4 earnings and revenue beat, driven by strong drug volumes, as attention turns to its late-stage MariTide obesity studies.